SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-467255
Filing Date
2016-02-17
Accepted
2016-02-17 17:17:37
Documents
7
Period of Report
2016-02-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 COMBO FORM 8K/425 d135149d8k.htm 8-K 52223
2 EX-2.1 d135149dex21.htm EX-2.1 124811
3 EX-2.2 d135149dex22.htm EX-2.2 123832
4 EX-2.3 d135149dex23.htm EX-2.3 88780
5 EX-2.4 d135149dex24.htm EX-2.4 92353
6 EX-10.1 d135149dex101.htm EX-10.1 567578
7 EX-99.1 d135149dex991.htm EX-99.1 103648
  Complete submission text file 0001193125-16-467255.txt   1154635
Mailing Address BUILDING 4, TRIDENT PLACE, MOSQUITO WAY HATFIELD, HERTFORDSHIRE X0 AL10 9UL
Business Address BUILDING 4, TRIDENT PLACE, MOSQUITO WAY HATFIELD, HERTFORDSHIRE X0 AL10 9UL 44 0 1707 853 000
Mylan N.V. (Filer) CIK: 0001623613 (see all company filings)

IRS No.: 981189497 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-199861 | Film No.: 161434328
SIC: 2834 Pharmaceutical Preparations